Abstract:To the Editor We read with great interest the recent article entitled “Fluorescent‐ guided surgery for sentinel lymph node detection in gastric cancer and carcinoembryonic antigen targeted fluorescent‐guided surgery in colorectal and pancreatic cancer” by Vuijk et al. This study foresaw a bright future for tumor‐specific imaging and staging strategy. The rationale for carcinoembryonic antigen (CEA) targeted imaging lies in (a) CEA highly expressed on tumour types and it was unaffected by neoadjuvant therapy, (b) anti‐CEA chimerized monoclonal antibody conjugated fluorochrome outperformed normal fluorescent reagents by molecular structure and diagnostic efficiency, and (c) safe tolerability and pharmacokinetics. The author overviewed preclinical and clinical studies and emphasized that the CEA targeted fluorescence were able to demarcate tumor nodules that could not be visualized in conventional bright light surgery. However, a very high tumor‐to‐background ratio measured ex vivo vs in vivo, and a certain extent of autofluorescence and background scattering previously described in fluorescence imaging studies potentially hinted a need for more sensitive intraoperative imaging systems. For colorectal cancer: Serum CEA levels were reported to be inadequate for rectal cancer patient selection because of a lack of correlation between tumor CEA expression and serum CEA levels. Preoperative cT staging assessment has always been a suitable and valid standard of patient selection. For pancreatic cancer: Disadvantageous CEA loss expression after neoadjuvant treatment was seen in pancreatic ductal adenocarcinoma. Serum CEA levels seem to be accurate to predict CEA tumor expression for fluorescence imaging surgery and posthospital follow up without a history of neoadjuvant treatment. For gastric cancer: Complicated lymphatic drainage and completely obliterated lymph channels (or nodes) have always been challenging for fluorescence imaging using indocyanine green (ICG) or ICG:NanoColl, underlining an urgent need for tumor‐specific fluorescent tracers for gastric cancer. The author foresaw a bright future for tumor‐specific imaging for gastric cancer. Whereas, the author was not sure if there exists a tumor‐targeted reagent that will wondrously outmatch pathological detection. In addition, what we especially want to propose is that a fluorescence imaging is just a macroscopic optical imaging, although it is combined with tumor‐specific regents in molecular level. To date, pathological testing remains a gold reference to discriminate cytological malignancy. Pathology molecular diagnostic techniques, such as reverse transcription‐polymerase chain reaction and one‐step nucleic acid amplification, have emerged as rapid, real‐time, and sensitive tools to detect lymph node micrometastasis. However, the time required to obtain results is still too long for use in the intraoperative diagnosis, and more studies are needed to improve these molecular tools. Therefore, future perspectives and expectations should look forward to tumor specific fluorescence imaging and these evolving and innovative pathological diagnosis techniques as well.

Molecular Fluorescence Endoscopy Targeting Vascular Endothelial Growth Factor A for Improved Colorectal Polyp Detection

A protease-activated, near-infrared fluorescent probe for early endoscopic detection of premalignant gastrointestinal lesions

Non-Invasive Discrimination of Colorectal Adenomas and Non-Neoplastic Polyps with Micro-Optical Coherence Tomography Imaging.

In Vivo Molecular Imaging of Epidermal Growth Factor Receptor in Patients with Colorectal Neoplasia Using Confocal Laser Endomicroscopy

Detection of Colonic Neoplasia in Vivo Using Near-Infrared-labeled Peptide Targeting Cmet.

Functional Genomic mRNA Profiling of Colorectal Adenomas: Identification and in vivo Validation of CD44 and Splice Variant CD44v6 as Molecular Imaging Targets

NIR-II Fluorescence Endoscopy for Targeted Imaging of Colorectal Cancer

Topical application of Chlorin e6-PVP (Ce6-PVP) for improved endoscopic detection of neoplastic lesions in a murine colitis-associated cancer model

EGFR Overexpressed in Colonic Neoplasia Can Be Detected on Wide-Field Endoscopic Imaging.

Intraoperative imaging of folate receptor alpha positive ovarian and breast cancer using the tumor specific agent EC17

Ex vivo optical coherence tomography combined with near infrared targeted fluorescence: towards in-vivo esophageal cancer detection

Multiplexed Endoscopic Imaging of Barrett’s Neoplasia Using Targeted Fluorescent Heptapeptides in a Phase 1 Proof-of-concept Study

Extracellular vesicles-based pre-targeting strategy enables multi-modal imaging of orthotopic colon cancer and image-guided surgery

Excessive Expectations for Carcinoembryonic Antigen Targeted Fluorescent‐guided Surgery for Sentinel Lymph Node Detection in Colorectal, Pancreatic, and Gastric Cancer

Detection of colonic dysplasia in patients with ulcerative colitis using a targeted fluorescent peptide and confocal laser endomicroscopy: A pilot study

Molecular in Vivo Imaging of Gastric Cancer in a Human-Murine Xenograft Model: Targeting Epidermal Growth Factor Receptor

Multimodality PET and Near-Infrared Fluorescence Intraoperative Imaging of CEA-Positive Colorectal Cancer

Preclinical Evaluation of a Novel EGFR&c-Met Bispecific Near Infrared Probe for Visualization of Esophageal Cancer and Metastatic Lymph Nodes.

Visible and Near Infrared Autofluorescence and Hyperspectral Imaging Spectroscopy for the Investigation of Colorectal Lesions and Detection of Exogenous Fluorophores

Back-Table Fluorescence-Guided Imaging for Circumferential Resection Margin Evaluation Using Bevacizumab-800CW in Patients with Locally Advanced Rectal Cancer

Can Vascular Endothelial Growth Factors and CD34 Expression Implement NICE (Narrow-Band Imaging International Colorectal Endoscopic) Classification in Colorectal Polypoid Lesion Diagnosis?